NASDAQ
COSM
Last Price
US $0.2065
Valuation
Financial
Performance
Cash flow to debt coverage
Cosmos Health Inc. cash flow to debt ratio of -42.30% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Cosmos Health Inc.'s free cash flow has decreased 4.53% from $-8.14M last year to $-8.50M, signaling decreasing performance
Debt-to-equity ratio
Cosmos Health Inc.'s debt to equity ratio is 0.88, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Cosmos Health Inc.'s debt has increased relative to shareholder equity from 0.48 last year to 0.88 today, signaling weakened financials
Net debt to EBITDA
Cosmos Health Inc. has negative EBITDA, making leverage ratio unreliable
Interest coverage
Cosmos Health Inc.'s interest coverage ratio is -5.87, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Cosmos Health Inc.'s profit margin has decreased (2.28%) in the last year from -29.73% to -30.41%, signaling decreasing performance
Current ratio
Cosmos Health Inc.'s short-term assets of $38.39M exceed its short-term liabilities of $38.27M
Return on assets
Cosmos Health Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Cosmos Health Inc.'s return on equity of -96.48%, is lower than 15.00%, indicating bad performance
Earnings quality
Cosmos Health Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Cosmos Health Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings
Positive free cash flow
Cosmos Health Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Cosmos Health Inc. has negative free cash flow, indicating cash burn
Earnings growth
Cosmos Health Inc.'s yearly earnings has decreased 18.30% since last year from $-16.18M to $-19.14M, signaling decreasing performance
Revenue growth
Cosmos Health Inc.'s yearly revenue has increased 19.93% since last year from $54.43M to $65.27M, signaling increasing performance
Return on invested capital
ROIC -45.73% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Cosmos Health Inc.'s 3-year revenue CAGR of 9.04% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Cosmos Health Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Cosmos Health Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity
Cash Flow Valuation (DCF)
Cosmos Health Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Cosmos Health Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
EBITDA Valuation
Cosmos Health Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
EV/EBITDA (FY)
Cosmos Health Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Cosmos Health Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Cosmos Health Inc. has a price-to-book ratio of 0.53x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Cosmos Health Inc. has a price-to-sales ratio of 0.15x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-96.48%
Return on equity
ROIC: -45.73%
Valuation History
-
Price to Earnings
EV/EBITDA: -1.7X
Cash flow
Profit margin
-
Cash flow
6.44%
Fair Value
Market $0.2065
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.